MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -54.71% | -62.21% | -17.98% | ||
| Total Depreciation and Amortization | -27.27% | -21.39% | 12.93% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 67.88% | 92.87% | -82.23% | ||
| Change in Net Operating Assets | -258.77% | -2,474.77% | -69.33% | ||
| Cash from Operations | -60.12% | -93.74% | -28.13% | ||
| Capital Expenditure | 91.71% | 77.08% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -1,603.85% | 114.40% | -- | ||
| Cash from Investing | -1,669.31% | 114.31% | 1,875,100.00% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 1,385.71% | -98.85% | 25.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -328.04% | 91.88% | -- | ||
| Cash from Financing | 95,780.19% | 90.81% | -100.04% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 368.62% | 88.17% | -88.10% | ||